Aug. 16, 2019 Price forecast | 2 weeks: 0.85% | 1 month: 1.70% | 3 months: 2.18%


NKTR stock forecast

Our latest prediction for Nektar Therapeutics's stock price was made on the Aug. 16, 2019 when the stock price was at 18.10$.

In the short term (2weeks), NKTR's stock price should outperform the market by 0.85%. During that period the price should oscillate between -6.73% and +15.18%.

In the medium term (3months), NKTR's stock price should outperform the market by 2.18%. During that period the price should oscillate between -14.59% and +40.88%.


About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The company focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.

At the moment the company generates 121M USD in revenues.

On its last earning announcement, the company reported a loss of -2.48$ per share.

The book value per share is 10.79$

Nektar Therapeutics website


Three months stock forecastAug. 16, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
121M 81.09% -431M -357.20% -425M -2.48 - - 176M 10.79 -321M -31M -352M